Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever

Pediatric Nephrology

Volumn 18, Issue 6, 2003, Pages 521-526

  Öner, Ayşe ^a   Erdoǧan, Özlem ^a   Demircin, Gülay ^a   Bülbül, Mehmet ^a   Memiş, Leyla ^b  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Amyloid nephropathy; Colchicine therapy; Familial Mediterranean fever

Indexed keywords

COLCHICINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; DRUG EFFECT; DRUG EFFICACY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0038498069     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1129-x     Document Type: Article

References (19)

1. Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26:612-627
2. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227-253
3. Goldfinger SE (1972) Colchicine for familial Mediterranean fever. New Engl J Med 287:1302
4. Gertz MA, Kyle RA (1994) Amyloidosis: prognosis and treatment. Semin Arthritis Rheum 24:124-138
5. Livneh A, Zemer D, Langevitz P, Shemer J, Sohar E, Pras M (1993) Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum 23:206-214
6. Zemer D, Livneh A, Langevitz P (1992) Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever. Ann Intern Med 116:426
7. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Eng J Med 314:1001-1005
8. Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M (1994) Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 37:1804-1811
9. Saatçi Ü, Özen S, Özdemir S, Bakkaloǧlu A, Beşbaş N, Topaloǧlu R, Arslan Ş (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619-623
10. Pras E, Livneh A, Balow JE Jr, Kastner DL, Pras M, Langevitz P (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216-219
11. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL (1998) Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 77:268-297
12. Saatçi Ü, Bakkaloǧlu A, Özen S, Beşbaş N (1993) Familial Mediterranean fever and amyloidosis in children. Acta Paediatr 81:705-706
13. Yalçinkaya F, Tekin M, Çakar N, Akar E, Akar N, Tümer N (2000) Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients. QJM 93:681-684
14. Meyerhoff J (1980) Familial Mediterranean fever: report of a large family, review of the literature, and discussion of the frequency of amyloidosis. Medicine (Baltimore) 59:66-77
15. Bohle A, Wehrmann M, Eissele R, Gise HV, Mackensen-Haen S, Müller C (1993) The long-term prognosis of AA and AL amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Pathol Res Pract 89:316-331
16. Schattner A (1991) Colchicine-expanding horizons. Postgrad Med J 67:223-226
17. Özen S, Uçkan D, Baskin E, Okur H, Beşbaş N, Saatçi Ü, Bakkaloǧlu A (2000) Apoptosis in Familial Mediterranean fever (abstract). Clin Exp Rheumatol 18:277
18. Bauer EA, Valle KJ (1982) Colchicine-induced modulation of collagenase in human skin fibroblast cultures. Stimulation of enzyme synthesis in normal cells. J Invest Dermatol 79: 398-402
19. Looi LM (1988) Histomorphological variations in systemic AA amyloidosis: clues of AA protein polymorphism. Histopathology 14:111-120